This is the first report of a patient presenting with rheumatoid factor (RF) positive hypertrophic cranial pachymeningitis (HCP) in association with hypopituitarism and multiple cranial nerve palsies. Our patient developed palsies of the left II and III, bilateral VI and VII, and right IX, X, and XII cranial nerves. A stimulation test showed hypopituitarism due to hypothalamic failure. The patient was seropositive for RF but had no multiple joint pain or deformities. Magnetic resonance imaging (MRI) showed thickened dura of the sellar and parasellar region, hypothalamus, bilateral cavernous sinuses and the tentorium all of which were enhanced by gadolinium (Gd). Treatment with prednisone improved clinical symptoms and MRIfindings concomitant with reduction of RF titer. Although the exact mechanism of HCPhas not been clearly elucidated, the present case suggests an autoimmune mechanism associated with RF. (Internal Medicine 40: 964-967, 2001) 
Introduction
Hypertrophic cranial pachymeningitis (HCP) is a rare chronic inflammatory disease that causes thickening of the dura mater. Only a few clinical cases were reported before the advent of computed tomography (CT), but the number reported has recently increased (1) (2) (3) . Amongthem, HCPin association with hypopituitarism and multiple cranial nerve palsies was reported in two of the cases, but both were negative for rheumatoid factor (RF) (4, 5) . Here, we report a unique case of RF positive HCPin association with hypopituitarism and multiple cranial nerve palsies. showed high signal intensity along the clivus, and thickening of the dura of the cavernous sinus, and tentorium was apparent ( Fig. 2A , B, C, arrowheads). Thickening also extended superiorly into the region of the diaphragma sella and the anterior cranial fossa. A Gd enhanced Tl-weighted coronal image showedhigh signal intensity in the cavernous sinus and the pituitary gland (Fig. 2D, arrowheads) . A midline Gd-enhanced Tl-weighted sagittal image showed pituitary gland, pituitary stalk and linear retroclinoid dural enhancement (Fig. 2E , arrowheads). MRangiography and electroencephalography (EEG) were normal. Clinical and neuro-imaging findings of our patient were consistent with pachymeningitis. The patient was treated with methylprednisolone pulse therapy at 500 mg/ day for 3 days, followed by 30 mg/day oral prednisolone. The clinical symptoms, especially those of the right IX, X, and XII cranial nerves, were gradually resolved. Serum RF level was reduced from 156 to 29 IU/ml and pituitary function also recovered. Follow-up brain MRIafter two courses of steroid pulse therapy slightly reduced Gd enhancement.
Discussion
HCPis a rare, chronic inflammatory disorder characterized by marked dural thickening, typically involving the cranial dura mater and the skull base dura. Long histories of headaches and progressive cranial nerve paresis are the common clinical symptoms, and cavernous sinus syndromeis also common (6) . In addition to multiple cranial nerve paresis caused by fibrous entrapment or ischemic damageof the nerve, adjacent tissue involvement such as encephalitis (7), hydrocephalus (8), sinus thrombosis (9), and pituitary lesions have been reported. Pituitary involvement has been observed in seven cases (4-8, 10). However,apparent hypopituitarism and multiple cranial nerve palsies wereobserved in only two cases apart from the present case (Table 2 ). This is the first case of RF positive HCPin association hypopituitarism and multiple cranial nerve palsies. Diffuse dural thickening has been found in pachymeningitis accompanying various conditions, such as syphilis (1 1), tuberculosis (12), fungal infection (13), Wegener' s granulomatosis (2), sarcoidosis (14), mixed connective tissue disease (15), intracranial hypotension (16), Tolosa-Hunt syndrome ( 17), and lymphomaor other neoplastic lesions (18) . However, none of the above matched the findings of the present patient. HCPis considered to be an autoimmunedisorder because of its association with other autoimmune disorders. HCPis associated with disorders such as, mixed connective tissue disorder and rheumatoid arthritis (RA) (15, 19, 20) . The present patient had a seropositive rheumatoid factor, but no multiple joint deformities. The patient did not satisfy the usual criteria of RA. Because our patient's symptoms improved and RF was reduced with steroid administration but reappeared several times whenever the steroid was decreased, the disorder in this patient is most likely due to an autoimmunemechanismassociated with RF. The natural course of HCPis poorly understood, and its management is not well defined. However,steroid therapy has been shown to be most effective in improving the symptoms and arresting the progression of HCP (21) . In our patient, steroid pulse therapy improved clinical symptoms and
MRIfindings concomitant with a reduction in RF titer. Although the previous two cases of hypopituitarism showed pituitary failure (4, 5) , test results of our patient suggest hypothalamic failure resulting in secondary pituitarism. In the hypothalamus, nerve cells secreting thyrotropin-releasing hormone (TRH) and growth hormone-releasing hormone (GH-RH)
are located medially, while the CRF and LH-RHreleasing cells are located in the outer side. Therefore, the secretion of CRF and LH-RHmay be more easily affected than that of TRHor GH-RH. Firstly, the endocrine abnormalities of our patient might be due to the hypothalamic parenchymatous involvement. Secondly the inflammed pituitary stalk seen in Gd-MRI might indicate that the pituitary portal system was compromisedfunctionally, thereby resulting in a dysfunctional anterior lobe. This report extends the spectrum of neurologic and endocrinologic manifestations of HCP.Although the exact mechanismof HCP has not been clearly elucidated, the present case suggests an autoimmunemechanismassociated with RF.
